nodes	percent_of_prediction	percent_of_DWPC	metapath
Dapagliflozin—ABCB1—adrenal gland cancer	0.805	1	CbGaD
Dapagliflozin—SLC5A4—urine—adrenal gland cancer	0.0587	0.362	CbGeAlD
Dapagliflozin—SLC5A2—urine—adrenal gland cancer	0.0445	0.274	CbGeAlD
Dapagliflozin—SLC5A11—pituitary gland—adrenal gland cancer	0.0114	0.0704	CbGeAlD
Dapagliflozin—SLC5A1—cardiac atrium—adrenal gland cancer	0.00739	0.0456	CbGeAlD
Dapagliflozin—Canagliflozin—ABCB1—adrenal gland cancer	0.00737	1	CrCbGaD
Dapagliflozin—SLC5A1—pituitary gland—adrenal gland cancer	0.00722	0.0445	CbGeAlD
Dapagliflozin—UGT2B4—cardiac atrium—adrenal gland cancer	0.00681	0.042	CbGeAlD
Dapagliflozin—CYP1A2—urine—adrenal gland cancer	0.00644	0.0397	CbGeAlD
Dapagliflozin—CYP2C9—urine—adrenal gland cancer	0.00611	0.0377	CbGeAlD
Dapagliflozin—CYP3A4—urine—adrenal gland cancer	0.00466	0.0287	CbGeAlD
Dapagliflozin—CYP2D6—urine—adrenal gland cancer	0.00459	0.0283	CbGeAlD
Dapagliflozin—UGT2B7—Codeine and Morphine Metabolism—ABCB1—adrenal gland cancer	0.00176	0.0687	CbGpPWpGaD
Dapagliflozin—CYP1A1—cardiac atrium—adrenal gland cancer	0.00139	0.00859	CbGeAlD
Dapagliflozin—ABCB1—adrenal cortex—adrenal gland cancer	0.000874	0.00539	CbGeAlD
Dapagliflozin—CYP2A6—Fluoropyrimidine Activity—RRM1—adrenal gland cancer	0.000818	0.032	CbGpPWpGaD
Dapagliflozin—ABCB1—gonad—adrenal gland cancer	0.000724	0.00447	CbGeAlD
Dapagliflozin—ABCB1—pituitary gland—adrenal gland cancer	0.000706	0.00436	CbGeAlD
Dapagliflozin—ABCB1—adrenal gland—adrenal gland cancer	0.000631	0.00389	CbGeAlD
Dapagliflozin—CYP2D6—Codeine and Morphine Metabolism—ABCB1—adrenal gland cancer	0.000617	0.0241	CbGpPWpGaD
Dapagliflozin—SLC5A4—Carbohydrate metabolism—PRKACA—adrenal gland cancer	0.000513	0.0201	CbGpPWpGaD
Dapagliflozin—UGT1A9—Constitutive Androstane Receptor Pathway—ABCB1—adrenal gland cancer	0.000471	0.0184	CbGpPWpGaD
Dapagliflozin—CYP3A4—Codeine and Morphine Metabolism—ABCB1—adrenal gland cancer	0.000403	0.0158	CbGpPWpGaD
Dapagliflozin—SLC5A1—Carbohydrate metabolism—PRKACA—adrenal gland cancer	0.000389	0.0152	CbGpPWpGaD
Dapagliflozin—SLC5A2—Carbohydrate metabolism—PRKACA—adrenal gland cancer	0.000389	0.0152	CbGpPWpGaD
Dapagliflozin—CYP2A6—Constitutive Androstane Receptor Pathway—ABCB1—adrenal gland cancer	0.000363	0.0142	CbGpPWpGaD
Dapagliflozin—SLC5A11—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.000356	0.0139	CbGpPWpGaD
Dapagliflozin—SLC5A4—Disease—SH3KBP1—adrenal gland cancer	0.000353	0.0138	CbGpPWpGaD
Dapagliflozin—SLC5A4—Metabolism—SDHB—adrenal gland cancer	0.000347	0.0136	CbGpPWpGaD
Dapagliflozin—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—PTGS2—adrenal gland cancer	0.000346	0.0135	CbGpPWpGaD
Dapagliflozin—SLC5A4—Disease—ZNRF3—adrenal gland cancer	0.000332	0.013	CbGpPWpGaD
Dapagliflozin—UGT1A9—PPARA activates gene expression—MED12—adrenal gland cancer	0.000302	0.0118	CbGpPWpGaD
Dapagliflozin—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—MED12—adrenal gland cancer	0.000296	0.0116	CbGpPWpGaD
Dapagliflozin—SLC5A11—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.000289	0.0113	CbGpPWpGaD
Dapagliflozin—SLC5A11—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.000283	0.0111	CbGpPWpGaD
Dapagliflozin—SLC5A1—Disease—SH3KBP1—adrenal gland cancer	0.000267	0.0105	CbGpPWpGaD
Dapagliflozin—SLC5A2—Disease—SH3KBP1—adrenal gland cancer	0.000267	0.0105	CbGpPWpGaD
Dapagliflozin—SLC5A1—Metabolism—SDHB—adrenal gland cancer	0.000263	0.0103	CbGpPWpGaD
Dapagliflozin—SLC5A2—Metabolism—SDHB—adrenal gland cancer	0.000263	0.0103	CbGpPWpGaD
Dapagliflozin—SLC5A4—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.00026	0.0102	CbGpPWpGaD
Dapagliflozin—SLC5A1—Disease—ZNRF3—adrenal gland cancer	0.000251	0.00983	CbGpPWpGaD
Dapagliflozin—SLC5A2—Disease—ZNRF3—adrenal gland cancer	0.000251	0.00983	CbGpPWpGaD
Dapagliflozin—UGT2B4—Biological oxidations—POMC—adrenal gland cancer	0.000227	0.00889	CbGpPWpGaD
Dapagliflozin—SLC5A4—Metabolism—SDHD—adrenal gland cancer	0.000224	0.00875	CbGpPWpGaD
Dapagliflozin—SLC5A4—Metabolism—RRM1—adrenal gland cancer	0.000224	0.00875	CbGpPWpGaD
Dapagliflozin—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—adrenal gland cancer	0.000221	0.00863	CbGpPWpGaD
Dapagliflozin—SLC5A4—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.000211	0.00824	CbGpPWpGaD
Dapagliflozin—SLC5A4—Disease—SPRY2—adrenal gland cancer	0.000208	0.00813	CbGpPWpGaD
Dapagliflozin—SLC5A4—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.000207	0.00808	CbGpPWpGaD
Dapagliflozin—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—MED12—adrenal gland cancer	0.000204	0.00797	CbGpPWpGaD
Dapagliflozin—UGT2B4—Metabolism—SDHB—adrenal gland cancer	0.000203	0.00795	CbGpPWpGaD
Dapagliflozin—CYP2C9—Constitutive Androstane Receptor Pathway—ABCB1—adrenal gland cancer	0.000202	0.00789	CbGpPWpGaD
Dapagliflozin—SLC5A1—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.000197	0.0077	CbGpPWpGaD
Dapagliflozin—SLC5A2—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.000197	0.0077	CbGpPWpGaD
Dapagliflozin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PRKACA—adrenal gland cancer	0.000193	0.00755	CbGpPWpGaD
Dapagliflozin—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—adrenal gland cancer	0.000192	0.00752	CbGpPWpGaD
Dapagliflozin—SLC5A4—Disease—MEN1—adrenal gland cancer	0.00019	0.00745	CbGpPWpGaD
Dapagliflozin—CYP1A1—PPARA activates gene expression—MED12—adrenal gland cancer	0.000174	0.00679	CbGpPWpGaD
Dapagliflozin—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—MED12—adrenal gland cancer	0.00017	0.00664	CbGpPWpGaD
Dapagliflozin—SLC5A2—Metabolism—SDHD—adrenal gland cancer	0.00017	0.00663	CbGpPWpGaD
Dapagliflozin—SLC5A1—Metabolism—RRM1—adrenal gland cancer	0.00017	0.00663	CbGpPWpGaD
Dapagliflozin—SLC5A1—Metabolism—SDHD—adrenal gland cancer	0.00017	0.00663	CbGpPWpGaD
Dapagliflozin—SLC5A2—Metabolism—RRM1—adrenal gland cancer	0.00017	0.00663	CbGpPWpGaD
Dapagliflozin—SLC5A4—Metabolism—MED12—adrenal gland cancer	0.000167	0.00653	CbGpPWpGaD
Dapagliflozin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—adrenal gland cancer	0.000164	0.00642	CbGpPWpGaD
Dapagliflozin—SLC5A1—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.00016	0.00624	CbGpPWpGaD
Dapagliflozin—SLC5A2—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.00016	0.00624	CbGpPWpGaD
Dapagliflozin—SLC5A2—Disease—SPRY2—adrenal gland cancer	0.000157	0.00616	CbGpPWpGaD
Dapagliflozin—SLC5A1—Disease—SPRY2—adrenal gland cancer	0.000157	0.00616	CbGpPWpGaD
Dapagliflozin—SLC5A1—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.000157	0.00613	CbGpPWpGaD
Dapagliflozin—SLC5A2—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.000157	0.00613	CbGpPWpGaD
Dapagliflozin—CYP2A6—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.000151	0.00589	CbGpPWpGaD
Dapagliflozin—SLC5A4—Disease—PRKACA—adrenal gland cancer	0.000145	0.00569	CbGpPWpGaD
Dapagliflozin—SLC5A2—Disease—MEN1—adrenal gland cancer	0.000144	0.00564	CbGpPWpGaD
Dapagliflozin—SLC5A1—Disease—MEN1—adrenal gland cancer	0.000144	0.00564	CbGpPWpGaD
Dapagliflozin—UGT1A9—Aryl Hydrocarbon Receptor Pathway—EGFR—adrenal gland cancer	0.000137	0.00534	CbGpPWpGaD
Dapagliflozin—CYP1A1—Aryl Hydrocarbon Receptor—RB1—adrenal gland cancer	0.000135	0.00527	CbGpPWpGaD
Dapagliflozin—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—adrenal gland cancer	0.000133	0.0052	CbGpPWpGaD
Dapagliflozin—UGT2B4—Metabolism—RRM1—adrenal gland cancer	0.000131	0.00512	CbGpPWpGaD
Dapagliflozin—UGT2B4—Metabolism—SDHD—adrenal gland cancer	0.000131	0.00512	CbGpPWpGaD
Dapagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—DAXX—adrenal gland cancer	0.000129	0.00503	CbGpPWpGaD
Dapagliflozin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—adrenal gland cancer	0.000127	0.00496	CbGpPWpGaD
Dapagliflozin—SLC5A2—Metabolism—MED12—adrenal gland cancer	0.000126	0.00495	CbGpPWpGaD
Dapagliflozin—SLC5A1—Metabolism—MED12—adrenal gland cancer	0.000126	0.00495	CbGpPWpGaD
Dapagliflozin—SLC5A4—Disease—CDC42—adrenal gland cancer	0.000123	0.00482	CbGpPWpGaD
Dapagliflozin—CYP2A6—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.000122	0.00477	CbGpPWpGaD
Dapagliflozin—SLC5A4—Metabolism—PRKACA—adrenal gland cancer	0.000122	0.00476	CbGpPWpGaD
Dapagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—RRM1—adrenal gland cancer	0.00012	0.00468	CbGpPWpGaD
Dapagliflozin—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—MED12—adrenal gland cancer	0.000117	0.00458	CbGpPWpGaD
Dapagliflozin—CYP2A6—Fluoropyrimidine Activity—TP53—adrenal gland cancer	0.000115	0.00451	CbGpPWpGaD
Dapagliflozin—CYP1A1—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.000112	0.00439	CbGpPWpGaD
Dapagliflozin—CYP1A1—Aryl Hydrocarbon Receptor—PTGS2—adrenal gland cancer	0.000111	0.00433	CbGpPWpGaD
Dapagliflozin—SLC5A1—Disease—PRKACA—adrenal gland cancer	0.00011	0.00431	CbGpPWpGaD
Dapagliflozin—SLC5A2—Disease—PRKACA—adrenal gland cancer	0.00011	0.00431	CbGpPWpGaD
Dapagliflozin—CYP1A1—Arachidonic acid metabolism—PTGS2—adrenal gland cancer	0.000104	0.00405	CbGpPWpGaD
Dapagliflozin—ABCB1—HIF-1-alpha transcription factor network—TERT—adrenal gland cancer	0.000104	0.00405	CbGpPWpGaD
Dapagliflozin—UGT2B7—Biological oxidations—POMC—adrenal gland cancer	0.000104	0.00405	CbGpPWpGaD
Dapagliflozin—SLC5A4—Disease—TERT—adrenal gland cancer	9.89e-05	0.00387	CbGpPWpGaD
Dapagliflozin—SLC5A4—Metabolism—GNAS—adrenal gland cancer	9.87e-05	0.00386	CbGpPWpGaD
Dapagliflozin—UGT2B4—Metabolism—MED12—adrenal gland cancer	9.76e-05	0.00382	CbGpPWpGaD
Dapagliflozin—SLC5A4—Metabolism—ABCB1—adrenal gland cancer	9.68e-05	0.00379	CbGpPWpGaD
Dapagliflozin—SLC5A1—Disease—CDC42—adrenal gland cancer	9.34e-05	0.00365	CbGpPWpGaD
Dapagliflozin—SLC5A2—Disease—CDC42—adrenal gland cancer	9.34e-05	0.00365	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—SDHB—adrenal gland cancer	9.26e-05	0.00362	CbGpPWpGaD
Dapagliflozin—SLC5A2—Metabolism—PRKACA—adrenal gland cancer	9.22e-05	0.00361	CbGpPWpGaD
Dapagliflozin—SLC5A1—Metabolism—PRKACA—adrenal gland cancer	9.22e-05	0.00361	CbGpPWpGaD
Dapagliflozin—CYP1A1—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	9.1e-05	0.00356	CbGpPWpGaD
Dapagliflozin—SLC5A4—Disease—BAD—adrenal gland cancer	8.6e-05	0.00337	CbGpPWpGaD
Dapagliflozin—CYP1A2—Aryl Hydrocarbon Receptor—RB1—adrenal gland cancer	8.59e-05	0.00336	CbGpPWpGaD
Dapagliflozin—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	8.44e-05	0.0033	CbGpPWpGaD
Dapagliflozin—UGT1A9—Biological oxidations—POMC—adrenal gland cancer	8.41e-05	0.00329	CbGpPWpGaD
Dapagliflozin—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	8.37e-05	0.00327	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	8.11e-05	0.00317	CbGpPWpGaD
Dapagliflozin—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—adrenal gland cancer	7.85e-05	0.00307	CbGpPWpGaD
Dapagliflozin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—adrenal gland cancer	7.85e-05	0.00307	CbGpPWpGaD
Dapagliflozin—SLC5A4—Disease—BRAF—adrenal gland cancer	7.83e-05	0.00306	CbGpPWpGaD
Dapagliflozin—CYP2C9—Arachidonic acid metabolism—PTGS2—adrenal gland cancer	7.73e-05	0.00302	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—SDHB—adrenal gland cancer	7.52e-05	0.00294	CbGpPWpGaD
Dapagliflozin—SLC5A1—Disease—TERT—adrenal gland cancer	7.5e-05	0.00293	CbGpPWpGaD
Dapagliflozin—SLC5A2—Disease—TERT—adrenal gland cancer	7.5e-05	0.00293	CbGpPWpGaD
Dapagliflozin—SLC5A1—Metabolism—GNAS—adrenal gland cancer	7.48e-05	0.00292	CbGpPWpGaD
Dapagliflozin—SLC5A2—Metabolism—GNAS—adrenal gland cancer	7.48e-05	0.00292	CbGpPWpGaD
Dapagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—TOP2A—adrenal gland cancer	7.39e-05	0.00289	CbGpPWpGaD
Dapagliflozin—SLC5A2—Metabolism—ABCB1—adrenal gland cancer	7.34e-05	0.00287	CbGpPWpGaD
Dapagliflozin—SLC5A1—Metabolism—ABCB1—adrenal gland cancer	7.34e-05	0.00287	CbGpPWpGaD
Dapagliflozin—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	7.15e-05	0.0028	CbGpPWpGaD
Dapagliflozin—UGT2B4—Metabolism—PRKACA—adrenal gland cancer	7.12e-05	0.00279	CbGpPWpGaD
Dapagliflozin—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—adrenal gland cancer	7.06e-05	0.00276	CbGpPWpGaD
Dapagliflozin—CYP2D6—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	6.85e-05	0.00268	CbGpPWpGaD
Dapagliflozin—CYP2C9—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	6.79e-05	0.00265	CbGpPWpGaD
Dapagliflozin—SLC5A4—Metabolism—POMC—adrenal gland cancer	6.64e-05	0.0026	CbGpPWpGaD
Dapagliflozin—CYP1A2—Arachidonic acid metabolism—PTGS2—adrenal gland cancer	6.6e-05	0.00258	CbGpPWpGaD
Dapagliflozin—SLC5A2—Disease—BAD—adrenal gland cancer	6.52e-05	0.00255	CbGpPWpGaD
Dapagliflozin—SLC5A1—Disease—BAD—adrenal gland cancer	6.52e-05	0.00255	CbGpPWpGaD
Dapagliflozin—CYP2A6—Biological oxidations—POMC—adrenal gland cancer	6.48e-05	0.00254	CbGpPWpGaD
Dapagliflozin—SLC5A4—Disease—PTGS2—adrenal gland cancer	6.33e-05	0.00247	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—SDHD—adrenal gland cancer	5.96e-05	0.00233	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—RRM1—adrenal gland cancer	5.96e-05	0.00233	CbGpPWpGaD
Dapagliflozin—SLC5A2—Disease—BRAF—adrenal gland cancer	5.94e-05	0.00232	CbGpPWpGaD
Dapagliflozin—SLC5A1—Disease—BRAF—adrenal gland cancer	5.94e-05	0.00232	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	5.92e-05	0.00232	CbGpPWpGaD
Dapagliflozin—CYP1A2—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	5.8e-05	0.00227	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—SDHB—adrenal gland cancer	5.8e-05	0.00227	CbGpPWpGaD
Dapagliflozin—UGT2B4—Metabolism—GNAS—adrenal gland cancer	5.77e-05	0.00226	CbGpPWpGaD
Dapagliflozin—UGT2B4—Metabolism—ABCB1—adrenal gland cancer	5.66e-05	0.00222	CbGpPWpGaD
Dapagliflozin—SLC5A4—Disease—CTNNB1—adrenal gland cancer	5.66e-05	0.00221	CbGpPWpGaD
Dapagliflozin—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	5.52e-05	0.00216	CbGpPWpGaD
Dapagliflozin—SLC5A4—Metabolism—PTGS2—adrenal gland cancer	5.3e-05	0.00207	CbGpPWpGaD
Dapagliflozin—SLC5A2—Metabolism—POMC—adrenal gland cancer	5.03e-05	0.00197	CbGpPWpGaD
Dapagliflozin—SLC5A1—Metabolism—POMC—adrenal gland cancer	5.03e-05	0.00197	CbGpPWpGaD
Dapagliflozin—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—adrenal gland cancer	5e-05	0.00196	CbGpPWpGaD
Dapagliflozin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—adrenal gland cancer	5e-05	0.00196	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—RRM1—adrenal gland cancer	4.85e-05	0.0019	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—SDHD—adrenal gland cancer	4.85e-05	0.0019	CbGpPWpGaD
Dapagliflozin—CYP1A1—Biological oxidations—POMC—adrenal gland cancer	4.83e-05	0.00189	CbGpPWpGaD
Dapagliflozin—SLC5A1—Disease—PTGS2—adrenal gland cancer	4.79e-05	0.00188	CbGpPWpGaD
Dapagliflozin—SLC5A2—Disease—PTGS2—adrenal gland cancer	4.79e-05	0.00188	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	4.66e-05	0.00182	CbGpPWpGaD
Dapagliflozin—SLC5A4—Disease—EGFR—adrenal gland cancer	4.48e-05	0.00175	CbGpPWpGaD
Dapagliflozin—CYP3A4—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	4.48e-05	0.00175	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—MED12—adrenal gland cancer	4.45e-05	0.00174	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—SDHB—adrenal gland cancer	4.32e-05	0.00169	CbGpPWpGaD
Dapagliflozin—SLC5A1—Disease—CTNNB1—adrenal gland cancer	4.29e-05	0.00168	CbGpPWpGaD
Dapagliflozin—SLC5A2—Disease—CTNNB1—adrenal gland cancer	4.29e-05	0.00168	CbGpPWpGaD
Dapagliflozin—SLC5A2—Metabolism—PTGS2—adrenal gland cancer	4.02e-05	0.00157	CbGpPWpGaD
Dapagliflozin—SLC5A1—Metabolism—PTGS2—adrenal gland cancer	4.02e-05	0.00157	CbGpPWpGaD
Dapagliflozin—UGT2B4—Metabolism—POMC—adrenal gland cancer	3.89e-05	0.00152	CbGpPWpGaD
Dapagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—adrenal gland cancer	3.85e-05	0.00151	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—RRM1—adrenal gland cancer	3.74e-05	0.00146	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—SDHD—adrenal gland cancer	3.74e-05	0.00146	CbGpPWpGaD
Dapagliflozin—CYP2D6—Biological oxidations—POMC—adrenal gland cancer	3.64e-05	0.00142	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—MED12—adrenal gland cancer	3.61e-05	0.00141	CbGpPWpGaD
Dapagliflozin—CYP2C9—Biological oxidations—POMC—adrenal gland cancer	3.6e-05	0.00141	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	3.48e-05	0.00136	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—SDHB—adrenal gland cancer	3.45e-05	0.00135	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	3.4e-05	0.00133	CbGpPWpGaD
Dapagliflozin—SLC5A1—Disease—EGFR—adrenal gland cancer	3.4e-05	0.00133	CbGpPWpGaD
Dapagliflozin—SLC5A2—Disease—EGFR—adrenal gland cancer	3.4e-05	0.00133	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—SDHB—adrenal gland cancer	3.25e-05	0.00127	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—PRKACA—adrenal gland cancer	3.24e-05	0.00127	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	3.23e-05	0.00126	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—SDHB—adrenal gland cancer	3.22e-05	0.00126	CbGpPWpGaD
Dapagliflozin—UGT2B4—Metabolism—PTGS2—adrenal gland cancer	3.1e-05	0.00121	CbGpPWpGaD
Dapagliflozin—CYP1A2—Biological oxidations—POMC—adrenal gland cancer	3.08e-05	0.0012	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	2.97e-05	0.00116	CbGpPWpGaD
Dapagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—adrenal gland cancer	2.83e-05	0.00111	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—MED12—adrenal gland cancer	2.79e-05	0.00109	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—RRM1—adrenal gland cancer	2.78e-05	0.00109	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—SDHD—adrenal gland cancer	2.78e-05	0.00109	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—SDHB—adrenal gland cancer	2.75e-05	0.00108	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—PRKACA—adrenal gland cancer	2.64e-05	0.00103	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—GNAS—adrenal gland cancer	2.63e-05	0.00103	CbGpPWpGaD
Dapagliflozin—ABCB1—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	2.58e-05	0.00101	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—ABCB1—adrenal gland cancer	2.58e-05	0.00101	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	2.58e-05	0.00101	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	2.54e-05	0.000992	CbGpPWpGaD
Dapagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—adrenal gland cancer	2.53e-05	0.000991	CbGpPWpGaD
Dapagliflozin—CYP3A4—Biological oxidations—POMC—adrenal gland cancer	2.38e-05	0.00093	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—SDHD—adrenal gland cancer	2.22e-05	0.00087	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—RRM1—adrenal gland cancer	2.22e-05	0.00087	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	2.17e-05	0.000848	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—GNAS—adrenal gland cancer	2.14e-05	0.000836	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—SDHB—adrenal gland cancer	2.13e-05	0.000831	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—ABCB1—adrenal gland cancer	2.1e-05	0.00082	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—RRM1—adrenal gland cancer	2.1e-05	0.000819	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—SDHD—adrenal gland cancer	2.1e-05	0.000819	CbGpPWpGaD
Dapagliflozin—ABCB1—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	2.09e-05	0.000819	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—RRM1—adrenal gland cancer	2.08e-05	0.000812	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—SDHD—adrenal gland cancer	2.08e-05	0.000812	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—MED12—adrenal gland cancer	2.08e-05	0.000812	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—PRKACA—adrenal gland cancer	2.03e-05	0.000795	CbGpPWpGaD
Dapagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—adrenal gland cancer	2.01e-05	0.000785	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	1.86e-05	0.000726	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—RRM1—adrenal gland cancer	1.77e-05	0.000694	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—SDHD—adrenal gland cancer	1.77e-05	0.000694	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—POMC—adrenal gland cancer	1.77e-05	0.000692	CbGpPWpGaD
Dapagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—adrenal gland cancer	1.68e-05	0.000659	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—MED12—adrenal gland cancer	1.66e-05	0.000648	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—GNAS—adrenal gland cancer	1.65e-05	0.000644	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—ABCB1—adrenal gland cancer	1.62e-05	0.000632	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—MED12—adrenal gland cancer	1.56e-05	0.000611	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—MED12—adrenal gland cancer	1.55e-05	0.000606	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—PRKACA—adrenal gland cancer	1.51e-05	0.000592	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	1.48e-05	0.000579	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—POMC—adrenal gland cancer	1.44e-05	0.000563	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—PTGS2—adrenal gland cancer	1.41e-05	0.000552	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	1.38e-05	0.000541	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—RRM1—adrenal gland cancer	1.37e-05	0.000536	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—SDHD—adrenal gland cancer	1.37e-05	0.000536	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—MED12—adrenal gland cancer	1.32e-05	0.000518	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—GNAS—adrenal gland cancer	1.23e-05	0.00048	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—PRKACA—adrenal gland cancer	1.21e-05	0.000473	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—ABCB1—adrenal gland cancer	1.2e-05	0.000471	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	1.18e-05	0.000463	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—PTGS2—adrenal gland cancer	1.15e-05	0.000449	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—PRKACA—adrenal gland cancer	1.14e-05	0.000446	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—PRKACA—adrenal gland cancer	1.13e-05	0.000442	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—POMC—adrenal gland cancer	1.11e-05	0.000434	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	1.1e-05	0.000432	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—MED12—adrenal gland cancer	1.02e-05	0.000399	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—GNAS—adrenal gland cancer	9.8e-06	0.000383	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—PRKACA—adrenal gland cancer	9.65e-06	0.000378	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	9.44e-06	0.000369	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—GNAS—adrenal gland cancer	9.24e-06	0.000361	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—GNAS—adrenal gland cancer	9.16e-06	0.000358	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—ABCB1—adrenal gland cancer	9.06e-06	0.000354	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—ABCB1—adrenal gland cancer	8.98e-06	0.000351	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—PTGS2—adrenal gland cancer	8.85e-06	0.000346	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—POMC—adrenal gland cancer	8.26e-06	0.000323	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—GNAS—adrenal gland cancer	7.82e-06	0.000306	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—ABCB1—adrenal gland cancer	7.68e-06	0.0003	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—PRKACA—adrenal gland cancer	7.45e-06	0.000291	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—POMC—adrenal gland cancer	6.6e-06	0.000258	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—PTGS2—adrenal gland cancer	6.59e-06	0.000258	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—POMC—adrenal gland cancer	6.22e-06	0.000243	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—POMC—adrenal gland cancer	6.16e-06	0.000241	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—GNAS—adrenal gland cancer	6.04e-06	0.000236	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—ABCB1—adrenal gland cancer	5.93e-06	0.000232	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—POMC—adrenal gland cancer	5.27e-06	0.000206	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—PTGS2—adrenal gland cancer	5.26e-06	0.000206	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—PTGS2—adrenal gland cancer	4.96e-06	0.000194	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—PTGS2—adrenal gland cancer	4.92e-06	0.000192	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—PTGS2—adrenal gland cancer	4.2e-06	0.000164	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—POMC—adrenal gland cancer	4.07e-06	0.000159	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—PTGS2—adrenal gland cancer	3.24e-06	0.000127	CbGpPWpGaD
